Publications by authors named "Annaik Dokhan"
Medicine (Baltimore)
February 2020
Article Synopsis
- Immunoglobulins are used as secondary or tertiary treatments for dermatomyositis (DM) and polymyositis (PM) when corticosteroids and immunosuppressants fail, typically administered intravenously once a month or subcutaneously at home a few times a week.
- A study involving seven patients (six with PM and one with DM) explored their experiences with both intravenous immunoglobulins (IVIg) and subcutaneous immunoglobulins (SCIg), revealing varied clinical profiles and significant improvements in symptoms after treatment.
- Patients found SCIg to be more convenient and less disruptive to daily life compared to IVIg, allowing them to regain autonomy and control over their treatment while still being effective and well tolerated.
Patient Prefer Adherence
March 2018
Article Synopsis
- - Patients with primary immunodeficiency (PID) often receive immunoglobulin replacement therapy (IgRT) via methods like subcutaneous infusions using either an automated pump (P) or manual syringe push (RP), with P being less frequent but longer in duration compared to the more frequent but quicker RP infusions.
- - A study involving interviews with PID patients revealed that while RP is slightly more cost-effective and has similar efficacy to P, many patients preferred P due to better integration into their daily routine and less frequent reminders of their disease.
- - The focus group indicated that the complexity of living with PID influences their delivery method preference, as patients found RP cumbersome and not necessarily time-saving, suggesting that healthcare providers should explore these personal experiences further
